Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-22T16:10:39.372Z Has data issue: false hasContentIssue false
  • English
  • Français

Haloperidol: A Controlled Clinical Trial in Chronic Disturbed Psychotic Patients

Published online by Cambridge University Press:  29 January 2018

A. Okasha  and
G. I. Tewfik
A. Okasha
Affiliation:
Scholar of Ain Shams University (Cairo) and Bexley Hospital
G. I. Tewfik
Affiliation:
Bexley Hospital
Get access Rights & Permissions [Opens in a new window]

Extract

Haloperidol is a drug that fulfils Delay's criteria of a neuroleptic in that:

  1. 1. It inhibits psychomotor agitation without producing sleep.

  2. 2. Alleviates psychomotor manifestations.

  3. 3. Produces with increasing dosage characteristic extrapyramidal signs.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 110 , Issue 464 , January 1964 , pp. 56 - 60
Copyright
Copyright © Royal College of Psychiatrists, 1964 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Brandrup, E. et al. (1961). J. Ment. Sci., 107, 778–782.CrossRefGoogle Scholar
Entwistle, C. et al. (19612). Ibid., 108, 373–375.Google Scholar
Garry, J. et al. (1962). Ibid., 108, 105–107.Google Scholar
Lucero, R. J., and Meyer, B. T. (1951). J. Clin. Psych., 7, No. 3.3.0.CO;2-G>CrossRefGoogle Scholar
Maurice, E. (1960). Acta Neurol. Psychiat. Belg., 60–97.Google Scholar
Rothstein, C. et al. (1962). J. Nerv. Merit. Dis., 134, 555.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.